We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that the U.S. Food and Drug Administration (FDA) ...
The Cardiac Resynchronization in Heart Failure (CARE-HF) [1] trial was an open-label, randomized, controlled study that evaluated the effects of cardiac resynchronization therapy (CRT) on morbidity ...
The European Society of Cardiology (ESC) has released updated guidelines for cardiac pacing and cardiac resynchronization therapy (CRT), which emphasize patient-centered care and shared ...
MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...
Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...
Cardiac resynchronization therapy has been shown to benefit patients with heart failure despite optimal medical therapy, but the effect on long-term outcomes is unknown. New research findings are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback